Recently, Cascade Pharmaceuticals, Inc announced that the clinical trial application of the new FXR agonist CS0159 for the indications of primary sclerosing cholangitis (PSC) jointly developed by the company's founder Eric Xu team of Shanghai Institute of pharmac。CS0159 is a new powerful non st
At 3 p.m. on September 16, 2020, the awarding ceremony of 2020 Shanghai "Magnolia Memorial Award" was held in Jing'an Shangri La Hotel. Dr. Eric Xu, founder of Cascade Pharmaceuticals, Inc, won the "Magnolia Memorial Award" of the year.Established in 1989, the "Magnolia
沪ICP备88888888号
